Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Total 13F shares
-
13,910,496
-
Share change
-
+1,256,883
-
Total reported value
-
$80,679,222
-
Put/Call ratio
-
62%
-
Price per share
-
$5.80
-
Number of holders
-
88
-
Value change
-
+$7,066,824
-
Number of buys
-
33
-
Number of sells
-
40
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q1 2024
As of 31 Mar 2024,
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,910,496 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, Woodline Partners LP, 683 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Janney Montgomery Scott LLC, Retirement Planning Co of New England, Inc., and Altium Capital Management LP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.